• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质纤维、微血管密度和免疫细胞群体的排列决定胰腺癌的总生存期-基质形态分析。

Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.

机构信息

Department of Surgery, University Medical Center Luebeck, Luebeck, Germany.

Department of General Surgery #1, Bogomolets National Medical University, Kyiv, Ukraine.

出版信息

PLoS One. 2020 Jul 13;15(7):e0234568. doi: 10.1371/journal.pone.0234568. eCollection 2020.

DOI:10.1371/journal.pone.0234568
PMID:32658932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7357746/
Abstract

INTRODUCTION

The aim of this study was to define histo-morphological stroma characteristics by analyzing stromal components, and to evaluate their impact on local and systemic tumor spread and overall survival in pancreatic ductal adenocarcinoma (PDAC).

METHODS AND MATERIALS

Patients who underwent oncologic resections with curative intent for PDAC were identified from a prospectively maintained database. Histological specimens were re-evaluated for morphological stroma features as stromal fibers, fibroblast morphology, stroma matrix density, microvessel density and distribution of immune cell populations.

RESULTS

A total of 108 patients were identified undergoing curative resection for PDAC in the period from 2011-2016. 33 (30.6%) patients showed parallel alignment of stroma fibers while 75 (69.4%) had randomly oriented stroma fibers. As compared to parallel alignment, random orientation of stroma fibers was associated with larger tumor size (median 3.62 cm vs. median 2.87cm, p = 0.037), nodal positive disease (76.0% vs. 54.5%, p = 0.040), higher margin positive resection rates (41.9% vs. 15.2%, p = 0.008) and a trend for higher rates of T3/4 tumors (33.3% vs. 15.2%, p = 0.064). In univariate analysis, patients with parallel alignment of stroma fibers had improved overall survival rates as compared to patients with random orientation of stroma fibers (42 months vs. 22 months, p = 0.046). The combination of random orientation of stroma fibers and low microvessel density was associated with impaired overall survival rates (16 months vs. 36 months, p = 0.019). A high CD4/CD3 ratio (16 months vs. 33 months, p = 0.040) and high stromal density of CD163 positive cells were associated with reduced overall survival (27 months vs. 34 months, p = 0.039). In multivariable analysis, the combination of random orientation of stroma fibers and low microvessel density (HR 1.592, 95%CI 1.098-2.733, p = 0.029), high CD4/CD3 ratio (HR 2.044, 95%CI 1.203-3.508, p = 0.028) and high density of CD163 positive cells (HR 1.596, 95%CI 1.367-1.968, p = 0.036) remained independent prognostic factors.

CONCLUSION

Alignment of stroma fibers and microvessel density are simple histomorphological features serving as surrogate markers of local tumor progression dissemination and surgical resectability and determine prognosis in PDAC patients. High CD4/CD3 ratio and CD163 positive cell counts determine poor prognosis.

摘要

简介

本研究旨在通过分析肿瘤基质成分来定义组织形态学基质特征,并评估其对胰腺导管腺癌(PDAC)局部和全身肿瘤扩散以及总生存的影响。

方法和材料

从一个前瞻性维护的数据库中确定了接受根治性切除术治疗 PDAC 的患者。对组织学标本进行了重新评估,以评估形态学基质特征,包括基质纤维、成纤维细胞形态、基质基质密度、微血管密度和免疫细胞群体分布。

结果

在 2011-2016 年期间,共确定了 108 例接受根治性切除术治疗 PDAC 的患者。33 例(30.6%)患者的基质纤维呈平行排列,75 例(69.4%)患者的基质纤维呈随机排列。与平行排列相比,基质纤维的随机排列与更大的肿瘤大小(中位数 3.62cm 与中位数 2.87cm,p=0.037)、阳性淋巴结疾病(76.0%与 54.5%,p=0.040)、更高的边缘阳性切除率(41.9%与 15.2%,p=0.008)和更高的 T3/4 肿瘤发生率趋势(33.3%与 15.2%,p=0.064)相关。在单因素分析中,与基质纤维随机排列的患者相比,基质纤维平行排列的患者总生存率更高(42 个月与 22 个月,p=0.046)。基质纤维随机排列和低微血管密度的组合与总生存率降低相关(16 个月与 36 个月,p=0.019)。CD4/CD3 比值高(16 个月与 33 个月,p=0.040)和 CD163 阳性细胞基质密度高与总生存率降低相关(27 个月与 34 个月,p=0.039)。在多因素分析中,基质纤维随机排列和低微血管密度的组合(HR 1.592,95%CI 1.098-2.733,p=0.029)、CD4/CD3 比值高(HR 2.044,95%CI 1.203-3.508,p=0.028)和 CD163 阳性细胞密度高(HR 1.596,95%CI 1.367-1.968,p=0.036)仍然是独立的预后因素。

结论

基质纤维的排列和微血管密度是简单的组织形态学特征,可作为局部肿瘤进展和扩散以及手术可切除性的替代标志物,并确定 PDAC 患者的预后。CD4/CD3 比值和 CD163 阳性细胞计数高预示预后不良。

相似文献

1
Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.基质纤维、微血管密度和免疫细胞群体的排列决定胰腺癌的总生存期-基质形态分析。
PLoS One. 2020 Jul 13;15(7):e0234568. doi: 10.1371/journal.pone.0234568. eCollection 2020.
2
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma.与接受手术切除的胰腺导管腺癌患者无进展生存期相关的免疫细胞和基质特征。
Gastroenterology. 2018 Nov;155(5):1625-1639.e2. doi: 10.1053/j.gastro.2018.08.009. Epub 2018 Aug 6.
3
Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.高度排列的基质胶原蛋白是胰腺导管腺癌切除术后的一个负性预后因素。
Oncotarget. 2016 Nov 15;7(46):76197-76213. doi: 10.18632/oncotarget.12772.
4
Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma.胰腺导管腺癌可切除患者的手术标本中存在胰腺纤维化、腺泡萎缩和慢性炎症与生存相关。
BMC Cancer. 2022 Jan 3;22(1):23. doi: 10.1186/s12885-021-09080-0.
5
Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.比较慢性胰腺炎和胰腺导管腺癌中基质细胞和导管上皮细胞的特征。
PLoS One. 2014 May 5;9(5):e94357. doi: 10.1371/journal.pone.0094357. eCollection 2014.
6
Pancreatic cancer stem cells may define tumor stroma characteristics and recurrence patterns in pancreatic ductal adenocarcinoma.胰腺癌干细胞可能定义胰腺导管腺癌中肿瘤基质特征和复发模式。
BMC Cancer. 2021 Apr 9;21(1):385. doi: 10.1186/s12885-021-08123-w.
7
Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma.胰腺腺癌中微血管密度及p53表达的评估
Clinics (Sao Paulo). 2016 Jul;71(6):315-9. doi: 10.6061/clinics/2016(06)05.
8
A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.基于 PD-L2 的免疫标志物特征有助于预测可切除胰腺导管腺癌的生存情况。
J Immunother Cancer. 2019 Aug 29;7(1):233. doi: 10.1186/s40425-019-0703-0.
9
Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma.激光捕获显微切割肿瘤的转录组分析揭示了胰腺导管腺癌的肿瘤和基质特异性分子亚型。
Clin Cancer Res. 2021 Apr 15;27(8):2314-2325. doi: 10.1158/1078-0432.CCR-20-1039. Epub 2021 Feb 5.
10
The M2 phenotype of tumor-associated macrophages in the stroma confers a poor prognosis in pancreatic cancer.基质中肿瘤相关巨噬细胞的M2表型预示着胰腺癌的预后不良。
Tumour Biol. 2016 Jul;37(7):8657-64. doi: 10.1007/s13277-015-4741-z. Epub 2016 Jan 6.

引用本文的文献

1
Spatially resolved analysis of TGF/BMP signalling in pancreatic ductal adenocarcinoma by digital pathology identifies patient subgroups with adverse outcome.通过数字病理学对胰腺导管腺癌中TGF/BMP信号进行空间分辨分析,可识别出预后不良的患者亚组。
BMC Cancer. 2025 Aug 18;25(1):1327. doi: 10.1186/s12885-025-14751-3.
2
The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity in Pancreatic Cancer Cells.mPSCs 与 Panc1 细胞的串扰分析确定 CCN1 是胰腺癌细胞中吉西他滨敏感性的正向调节剂。
Int J Mol Sci. 2024 Aug 29;25(17):9369. doi: 10.3390/ijms25179369.
3

本文引用的文献

1
Prognostic impact of tumour-infiltrating lymphocytes and cancer-associated fibroblasts in patients with pancreatic adenocarcinoma of the body and tail undergoing resection.肿瘤浸润淋巴细胞和癌相关成纤维细胞对接受切除术的体尾部胰腺腺癌患者的预后影响。
Br J Surg. 2020 May;107(6):720-733. doi: 10.1002/bjs.11434. Epub 2020 Jan 21.
2
Promising new treatments for pancreatic cancer in the era of targeted and immune therapies.在靶向治疗和免疫治疗时代,胰腺癌有前景的新疗法。
Am J Cancer Res. 2019 Sep 1;9(9):1871-1888. eCollection 2019.
3
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan.
Biophysical perspectives to understanding cancer-associated fibroblasts.
理解癌症相关成纤维细胞的生物物理学视角。
APL Bioeng. 2024 Jun 6;8(2):021507. doi: 10.1063/5.0199024. eCollection 2024 Jun.
4
Different Periampullary Types and Subtypes Leading to Different Perioperative Outcomes of Pancreatoduodenectomy: Reality and Not a Myth; An International Multicenter Cohort Study.不同的壶腹周围类型和亚型导致胰十二指肠切除术不同的围手术期结局:现实而非神话;一项国际多中心队列研究。
Cancers (Basel). 2024 Feb 23;16(5):899. doi: 10.3390/cancers16050899.
5
Desmoplastic stromal signatures predict patient outcomes in pancreatic ductal adenocarcinoma.促结缔组织增生性基质特征可预测胰腺导管腺癌患者的预后。
Cell Rep Med. 2023 Nov 21;4(11):101248. doi: 10.1016/j.xcrm.2023.101248. Epub 2023 Oct 20.
6
Quantitative intravital imaging for real-time monitoring of pancreatic tumor cell hypoxia and stroma in an orthotopic mouse model.定量活体成像实时监测原位小鼠模型中胰腺肿瘤细胞缺氧和基质
Sci Adv. 2023 Jun 9;9(23):eade8672. doi: 10.1126/sciadv.ade8672. Epub 2023 Jun 7.
7
High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma.血清中V型胶原C端前肽(PRO-C5)水平升高是胰腺导管腺癌患者总生存期短的预后指标。
Front Mol Biosci. 2023 Mar 10;10:1158058. doi: 10.3389/fmolb.2023.1158058. eCollection 2023.
8
The Functional Role of LncRNA UCA1 in Pancreatic Cancer: a mini-review.长链非编码RNA UCA1在胰腺癌中的功能作用:一篇综述。
J Cancer. 2023 Jan 9;14(2):275-280. doi: 10.7150/jca.79171. eCollection 2023.
9
Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer.靶向 EGFR 的光激活多抑制剂脂质体缓解胰腺癌细胞外基质可使总生存期翻倍。
Adv Sci (Weinh). 2022 Aug;9(24):e2104594. doi: 10.1002/advs.202104594. Epub 2022 Jun 24.
10
Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma.胶原蛋白生物标志物可在体外量化成纤维细胞活性,并预测胰腺导管腺癌患者的生存率。
Cancers (Basel). 2022 Feb 6;14(3):819. doi: 10.3390/cancers14030819.
胰腺癌细胞 p53 状态驱动的 CAF 层级结构通过硫酸乙酰肝素蛋白聚糖(perlecan)形成促转移和化疗耐药的微环境。
Nat Commun. 2019 Aug 12;10(1):3637. doi: 10.1038/s41467-019-10968-6.
4
The Importance of a Conjoint Analysis of Tumor-Associated Macrophages and Immune Checkpoints in Pancreatic Cancer.肿瘤相关巨噬细胞与免疫检查点在胰腺癌中的联合分析的重要性。
Pancreas. 2019 Aug;48(7):904-912. doi: 10.1097/MPA.0000000000001364.
5
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer.基质微环境塑造胰腺癌的肿瘤内结构。
Cell. 2019 Jun 27;178(1):160-175.e27. doi: 10.1016/j.cell.2019.05.012. Epub 2019 May 30.
6
Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.胰腺导管腺癌中的成纤维细胞:生物学机制和治疗靶点。
Gastroenterology. 2019 May;156(7):2085-2096. doi: 10.1053/j.gastro.2018.12.044. Epub 2019 Feb 2.
7
Stromal Content Is Correlated With Tissue Site, Contrast Retention, and Survival in Pancreatic Adenocarcinoma.基质含量与胰腺腺癌的组织部位、造影剂滞留及生存情况相关。
JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00121. Epub 2018 Jan 16.
8
QuPath: Open source software for digital pathology image analysis.QuPath:用于数字病理学图像分析的开源软件。
Sci Rep. 2017 Dec 4;7(1):16878. doi: 10.1038/s41598-017-17204-5.
9
Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells.基质硬度诱导胰腺癌细胞发生上皮-间质转化并促进其化疗耐药性。
Oncogenesis. 2017 Jul 3;6(7):e352. doi: 10.1038/oncsis.2017.54.
10
The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors.成纤维细胞在胰腺癌中的作用:细胞外基质与旁分泌因子
Transl Oncol. 2017 Aug;10(4):578-588. doi: 10.1016/j.tranon.2017.04.009. Epub 2017 Jun 26.